Dr. rer. nat. Torsten Viergutz

+49 38208 68-752
Leibniz-Institut für Nutztierbiologie (FBN)
Institut für Fortpflanzungsbiologie
Servicegruppe Zytometrie
Wilhelm-Stahl-Allee 2
18196 Dummerstorf

Forschungsinteressen

Oxidativer Stress, Follikuläre Dysfunktion, Physiologie des Rindes, Lipidmetabolismus, Zellsignal-Übertragungswege, Apoptose und Proliferation, Durchflusszytometrie

berufliche Aktivitäten

Mitglied im Vorstand der Deutschen Gesellschaft für Zytometrie DGfZ

Publikationen

Richard, D.; Lange, S.; Viergutz, T.; Kriehuber, R.; Weiss, D.; Simko', M. (2002):
Influence of 50 Hz electromagnetic fields in combination with a tumour promoting phorbol ester on protein kinase C and cell cycle in human cells. Mol Cell Biochem 232 (1-2): 133-141
Lange, S.; Richard, D.; Viergutz, T.; Kriehuber, R.; Weiss, D.; Simko', M. (2002):
Alterations in the cell cycle and in the protein level of cyclin D1, p21CIP1, and p16INK4a after exposure to 50 Hz MF in human cells. Radiat Environ Bioph 41 (2): 131-137
Löhrke, B.; Viergutz, T.; Shen, Z.; Derno, M.; Hagemeister, H. (2002):
Responses of intracellular prion protein levels in the bovine hypothalamus and rumen papillae to an increase in dietary metabolizable energy. Clin Neuropathol 21 (4): 180-181
Tiemann, U.; Viergutz, T.; Jonas, E; Wollenhaupt, K.; Pöhland, R.; Kanitz, W. (2001):
Fluorometric detection of platelet activating factor receptor in cultured oviductal epithelial and stromal cells and endometrial stromal cells from bovine at different stages of the oestrus cycle and early pregnancy. DOMEST ANIM ENDOCRIN 20 (3): 149-164
Viergutz, T. (2001):
Die Beziehung zwischen dem peroxisomenproliferatoraktivierten Rezeptor- gamma (PPARg) und dem Zellzyklus in großen Luteinzellen vom Rind Universität Rostock, Rostock: 1-65
Viergutz, T.; Löhrke, B.; Pöhland, R.; Becker, F.; Kanitz, W. (2000):
Relationship between different stages of the corpus luteum and the expression of the peroxisome proliferator-activated receptor γ protein in bovine large lutein cells. J Reprod Fertil 118 (1): 153-161
Löhrke, B.; Dietl, G.; Renne, U.; Viergutz, T.; Becker, F.; Kanitz, W. (1999):
The transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) as a potential mediator of associations between metabolic and reproductive disorders. Arch Tierzucht 42: 138-142
Tiemann, U.; Pöhland, R.; Küchenmeister, U.; Viergutz, T. (1998):
Influence of organochlorine pesticides on transmembrane potential, oxidative activity, and ATP-induced calcium release in cultured bovine oviductal cells. Reprod Toxicol 12 (5): 551-557
Löhrke, B.; Viergutz, T.; Shahi, S.K.; Pöhland, R.; Wollenhaupt, K.; Goldammer, T.; Walzel, H.; Kanitz, W. (1998):
Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endocrinol 159 (3): 429-439
Löhrke, B.; Derno, M.; Krüger, B.; Viergutz, T.; Matthes, H.-D.; Jentsch, W. (1997):
Expression of sulphonylurea receptors in bovine monocytes from animals with a different metabolic rate. Pflug Arch Eur J Phy 434 (6): 712-720
Löhrke, B.; Renne, U.; Viergutz, T.; Ender, K.; Krüger, B. (1996):
Effects of stress-related signal molecules on cells associated with muscle tissue. Anal Quant Cytol 18 (5): 383-388
Löhrke, B.; Wegner, J.; Viergutz, T.; Dietl, G.; Ender, K. (1995):
Flow-cytometric analysis of oxidative and proteolytical activities in tissue-associated phagocytes from normal and hypertrophic muscles. Anal Cell Pathol 9 (4): 281-293
Löhrke, B.; Köwitz, J.; Hansen, P.j.; Viergutz, T. (1993):
Mögliche prognostische Kriterien zur Beurteilung der bei Schweinen sich durch Belastung erhöhenden Anfälligkeit gegenüber septischen Erkrankungen. Berl Munch Tierarztl 106: 49-55
Löhrke, B.; Krüger, B.; Viergutz, T. (1993):
The glycosylation as source of the variability in prolactin patterns of individual human amniotic fluids. Biol Chem H-S 374 (4): 271-279
Löhrke, B.; Kunkel, S.; Köwitz, J.; Viergutz, T.; Tiemann, U.; Alm, H.; Krüger, B. (1993):
Prolactin heterogeneity - a limitation on the evaluation of results from prolactin assays due to differences in immunoassays and the different bioactivities of prolactin forms. Eur J Clin Chem Clin 31 (12): 815-827